Kupfer D, First M, Regier D, (eds). A Research Agenda for DSM–V. American Psychiatric Publishing, 2002.
Kupfer D, Regier D, Kuhl E. On the road to DSM–V and ICD–11. Eur Arch Psychiatry Clin Neuroscience
2008; 258 (suppl 5): 2–6.
Koob G. The neurobiology of addiction: a neuroadaptational view relevant for diagnosis. Addiction
2006; 101: 23–30.
Sunderland T, Hampel H, Takeda M, Putnam KT, Cohen RM. Biomarkers in the diagnosis of Alzheimer's disease: are we ready?
J Geriatr Psychiatry Neurol
2006; 19: 172–9.
Benes F. Searching for unique endophenotypes for schizophrenia and bipolar disorder within neural circuits and their molecular regulatory mechanisms. Schizophr Bull
2007; 33: 932–6.
Hyman S. Can neuroscience be integrated into the DSM–V?
Nature Rev Neurosci
2007; 8: 725–32.
Helzer JE, Kraemer HC, Krueger RF, Wittchen H-U, Sirovatka PJ, Regier DA, (eds). Dimensional Approaches in Diagnostic Classification: Refining the Research Agenda for DSM–V. American Psychiatric Association, 2008.
Frances A. Dimensional diagnosis of personality – not whether, but when and which. Psychol Inquiry
1993; 4: 110–1.
Corcoran C, Malaspina D, Hercher L. Prodromal interventions for schizophrenia vulnerability: the risks of being ‘at risk’. Schizophr Res
2005; 73: 173–84.
First M, Frances A. Issues for DSM–V; Unintended consequences of small changes: the case of paraphilias. Am J Psychiatry
2008; 165: 1240–1.
Widiger TA, Frances AJ, Pincus HA, Davis WW, First . Toward an empirical classification for the DSM–IV. J Abnorm Psychol
1991; 100: 280–8.
Task Force on DSM–IV. DSM–IV Options Book: Work in Progress 9/1/99. American Psychiatric Association, 1991.
First M. Harmonization of ICD–11 and DSM–V: opportunities and challenges. Br J Psychiatry
2009; 195: 382–90.